Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc

Siglecs and their roles in the immune system

Crocker, P. R., Paulson, J. C., & Varki, A. P. (2007) · Nature reviews. Immunology · doi:10.1038/nri2056 · Cited by 2,032 · see citing works

Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation

Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754 · see citing works

The Impact of Glycosylation on the Biological Function and Structure of Human Immunoglobulins

Arnold, J. N., Wormald, M. R., Sim, R. B., Rudd, P. M., & Dwek, R. A. (2006) · Annual Review of Immunology · doi:10.1146/annurev.immunol.25.022106.141702 · Cited by 1,308 · see citing works

Anti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor

Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,051 · see citing works

Divergent Immunoglobulin G Subclass Activity Through Selective Fc Receptor Binding

Nimmerjahn, F., & Ravetch, J. V. (2005) · Science · doi:10.1126/science.1118948 · Cited by 1,040 · see citing works

Glycan-based interactions involving vertebrate sialic-acid-recognizing proteins

Varki, A. P. (2007) · Nature · doi:10.1038/nature05816 · Cited by 855 · see citing works

From Systemic T Cell Self-Reactivity to Organ-Specific Autoimmune Disease via Immunoglobulins

Korganow, A., Ji, H., Mangialaio, S., Duchatelle, V., Pelanda, R., Martin, T., Degott, C., Kikutani, H., Rajewsky, K., Pasquali, J., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80045-x · Cited by 691 · see citing works

A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission

Tumpey, T. M., Maines, T. R., Hoeven, N. V., Glaser, L. J., Solórzano, A., Pappas, C., Cox, N. J., Swayne, D. E., Palese, P., Katz, J. M., et al. (2007) · Science · doi:10.1126/science.1136212 · Cited by 575 · see citing works

Higher levels of sialylated Fc glycans in immunoglobulin G molecules can adversely impact functionality

Scallon, B. J., Tam, S. H., McCarthy, S. G., Cai, A. N., & Raju, T. S. (2006) · Molecular Immunology · doi:10.1016/j.molimm.2006.09.005 · Cited by 397 · see citing works

Influenza Virus Receptor Specificity and Cell Tropism in Mouse and Human Airway Epithelial Cells

Ibricevic, A., Pekosz, A. S., Walter, M. J., Newby, C. M., Battaile, J. T., Brown, E. G., Holtzman, M. J., & Brody, S. L. (2006) · Journal of Virology · doi:10.1128/jvi.02677-05 · Cited by 394 · see citing works

Immune regulation by the ST6Gal sialyltransferase.

Hennet, T., Chui, D., Paulson, J., & Marth, J. (1998) · Proceedings of the National Academy of Sciences of the United States of America · doi:10.1073/pnas.95.8.4504 · Cited by 366 · see citing works

Colony-Stimulating Factor-1-Dependent Macrophages Are Responsible for IVIG Protection in Antibody-Induced Autoimmune Disease

Bruhns, P., Samuelsson, A., Pollard, J. W., & Ravetch, J. V. (2003) · Immunity · doi:10.1016/s1074-7613(03)00080-3 · Cited by 305 · see citing works

The antiinflammatory activity of IgG: the intravenous IgG paradox

Nimmerjahn, F., & Ravetch, J. V. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20061788 · Cited by 279 · see citing works

Differential expression of five sialyltransferase genes in human tissues.

Kitagawa, H., & Paulson, J. C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32390-6 · Cited by 254 · see citing works

A malaria invasion receptor, the 175-kilodalton erythrocyte binding antigen of Plasmodium falciparum recognizes the terminal Neu5Ac(alpha 2-3)Gal- sequences of glycophorin A.

Orlandi, P. A., Klotz, F. W., & Haynes, J. D. (1992) · The Journal of Cell Biology · doi:10.1083/jcb.116.4.901 · Cited by 249 · see citing works

Pathology and protection in nephrotoxic nephritis is determined by selective engagement of specific Fc receptors

Kaneko, Y., Nimmerjahn, F., Madaio, M. P., & Ravetch, J. V. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20051900 · Cited by 246 · see citing works

Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells

Siragam, V., Crow, A. R., Brinc, D., Song, S. M., Freedman, J. J., & Lazarus, A. H. (2006) · Nature Medicine · doi:10.1038/nm1416 · Cited by 246 · see citing works

Sialic acid-specific lectins: occurrence, specificity and function

Lehmann, F., Tiralongo, E., & Tiralongo, J. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5589-y · Cited by 243 · see citing works

Congruent Strategies for Carbohydrate Sequencing. 1. Mining Structural Details by MS n

Ashline, D. J., Singh, S., Hanneman, A., & Reinhold, V. N. (2005) · Analytical Chemistry · doi:10.1021/ac050724z · Cited by 232 · see citing works

Variations in Oligosaccharide−Protein Interactions in Immunoglobulin G Determine the Site-Specific Glycosylation Profiles and Modulate the Dynamic Motion of the Fc Oligosaccharides

Wormald, M. R., Rudd, P. M., Harvey, D. J., Chang, S.-C., Scragg, I. G., & Dwek, R. A. (1997) · Biochemistry · doi:10.1021/bi9621472 · Cited by 191 · see citing works

Characterization of a Plasmodium falciparum erythrocyte-binding protein paralogous to EBA-175

Mayer, D. C. G., Kaneko, O., Hudson, D. E., Reid, M. E., & Miller, L. H. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.081075398 · Cited by 171 · see citing works

A comparative study of the N-linked oligosaccharide structures of human IgG subclass proteins.

Jefferis, R., Lund, J., Mizutani, H., Nakagawa, H., Kawazoe, Y., Arata, Y., & Takahashi, N. (1990) · Biochemical Journal · doi:10.1042/bj2680529 · Cited by 166 · see citing works

Comparative structural study of the N-linked oligosaccharides of human normal and pathological immunoglobulin G

Takahashi, N., Ishii, I., Ishihara, H., Mori, M., Tejima, S., Jefferis, R., Endo, S., & Arata, Y. (1987) · Biochemistry · doi:10.1021/bi00378a023 · Cited by 163 · see citing works

FcγRIII-Dependent Inhibition of Interferon-γ Responses Mediates Suppressive Effects of Intravenous Immune Globulin

Park‐Min, K., Serbina, N. V., Yang, W., Ma, X., Krystal, G., Neel, B. G., Nutt, S. L., Hu, X., & Ivashkiv, L. B. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.010 · Cited by 158 · see citing works

Carbohydrate Structural Isomers Analyzed by Sequential Mass Spectrometry

Ashline, D. J., Lapadula, A. J., Liu, Y., Lin, M. C., Grace, M., Pramanik, B., & Reinhold, V. N. (2007) · Analytical Chemistry · doi:10.1021/ac062383a · Cited by 151 · see citing works

Glycoengineering of Therapeutic Glycoproteins: In Vitro Galactosylation and Sialylation of Glycoproteins with Terminal N-Acetylglucosamine and Galactose Residues

Raju, T. S., Briggs, J. B., Chamow, S. M., Winkler, M. E., & Jones, A. J. S. (2001) · Biochemistry · doi:10.1021/bi010475i · Cited by 122 · see citing works

The Glycosylation of Human Serum IgD and IgE and the Accessibility of Identified Oligomannose Structures for Interaction with Mannan-Binding Lectin

Arnold, J. N., Radcliffe, C. M., Wormald, M. R., Royle, L., Harvey, D. J., Crispin, M., Dwek, R. A., Sim, R. B., & Rudd, P. M. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.173.11.6831 · Cited by 110 · see citing works

Ultrastructural localization of a macrophage-restricted sialic acid binding hemagglutinin, SER, in macrophage-hematopoietic cell clusters

Crocker, P. R., Werb, Z., Gordon, S., & Bainton, D. (1990) · Blood · doi:10.1182/blood.v76.6.1131.1131 · Cited by 101 · see citing works

α2,3‐Sialyltransferase‐IV is essential for L‐selectin ligand function in inflammation

Sperandio, M., Frommhold, D., Babushkina, I., Ellies, L. G., Olson, T. S., Smith, M. L., Fritzsching, B., Pauly, E., Smith, D. F., Nobiling, R., et al. (2006) · European Journal of Immunology · doi:10.1002/eji.200636157 · Cited by 68 · see citing works

Large-scale expression of recombinant sialyltransferases and comparison of their kinetic properties with native enzymes

Williams, M. A., Kitagawa, H., Datta, A. K., Paulson, J. C., & Jamieson, J. C. (1995) · Glycoconjugate Journal · doi:10.1007/bf00731235 · Cited by 59 · see citing works

In vitro galactosylation of human IgG at 1 kg scale using recombinant galactosyltransferase

Warnock, D. E., Bai, X., Autote, K., Gonzales, J., Kinealy, K., Yan, B., Qian, J., Stevenson, T., Zopf, D. A., & Bayer, R. J. (2005) · Biotechnology and Bioengineering · doi:10.1002/bit.20658 · Cited by 53 · see citing works

Restricted reassociation of heavy and light chains from hapten-specific monoclonal antibodies.

Kranz, D. M., & Voss, E. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.9.5807 · Cited by 49 · see citing works

Specificity of S fimbriae on recombinant Escherichia coli: preferential binding to gangliosides expressing NeuGc alpha (2-3)Gal and NeuAc alpha (2-8)NeuAc

Hanisch, F., Hacker, J. H., & Schroten, H. (1993) · Infection and Immunity · doi:10.1128/iai.61.5.2108-2115.1993 · Cited by 40 · see citing works

Lectin analysis of human immunoglobulin G N-glycan sialylation

Dalziel, M., McFarlane, I., & Axford, J. S. (1999) · Glycoconjugate Journal · doi:10.1023/a:1007183915921 · Cited by 35 · see citing works

Biological roles of glycans

Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635 · see citing works

IgG Subclasses and Allotypes: From Structure to Effector Functions

Vidarsson, G., Dekkers, G., & Rispens, T. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00520 · Cited by 2,667 · see citing works

Intravenous immunoglobulin therapy: how does IgG modulate the immune system?

Schwab, I., & Nimmerjahn, F. (2013) · Nature reviews. Immunology · doi:10.1038/nri3401 · Cited by 818 · see citing works

Glycosylation as a strategy to improve antibody-based therapeutics

Jefferis, R. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2804 · Cited by 829 · see citing works

Mammalian glycosylation in immunity

Marth, J. D., & Grewal, P. K. (2008) · Nature reviews. Immunology · doi:10.1038/nri2417 · Cited by 705 · see citing works

Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway

Anthony, R. M., Kobayashi, T., Wermeling, F., & Ravetch, J. (2011) · Nature · doi:10.1038/nature10134 · Cited by 625 · see citing works

Identification of a receptor required for the anti-inflammatory activity of IVIG

Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 544 · see citing works

High Throughput Isolation and Glycosylation Analysis of IgG–Variability and Heritability of the IgG Glycome in Three Isolated Human Populations

Pučić‐Baković, M., Knežević, A., Vidič, J., Adamczyk, B., Novokmet, M., Polašek, O., Gornik, O., Goreta, S. Š., Wormald, M. R., Redžić, I., et al. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m111.010090 · Cited by 521 · see citing works

Terminal sugars of Fc glycans influence antibody effector functions of IgGs

Raju, T. S. (2008) · Current Opinion in Immunology · doi:10.1016/j.coi.2008.06.007 · Cited by 521 · see citing works

Type I and type II Fc receptors regulate innate and adaptive immunity

Pincetic, A., Bournazos, S., DiLillo, D. J., Maamary, J., Wang, T. T., Dahan, R., Fiebiger, B. M., & Ravetch, J. V. (2014) · Nature Immunology · doi:10.1038/ni.2939 · Cited by 504 · see citing works

Glycosylation: mechanisms, biological functions and clinical implications

He, M., Zhou, X., & Wang, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01886-1 · Cited by 542 · see citing works

Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases

Gelfand, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1009433 · Cited by 497 · see citing works

Human plasma protein N-glycosylation

Clerc, F., Reiding, K. R., Jansen, B. C., Lageveen‐Kammeijer, G. S. M., Bondt, A., & Wuhrer, M. (2015) · Glycoconjugate Journal · doi:10.1007/s10719-015-9626-2 · Cited by 450 · see citing works

Antibody Glycosylation and Its Impact on the Pharmacokinetics and Pharmacodynamics of Monoclonal Antibodies and Fc-Fusion Proteins

Liu, L. (2015) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.24444 · Cited by 428 · see citing works

Emerging principles for the therapeutic exploitation of glycosylation

Dalziel, M., Crispin, M., Scanlan, C. N., Zitzmann, N., & Dwek, R. A. (2014) · Science · doi:10.1126/science.1235681 · Cited by 447 · see citing works

Immunoglobulin G glycosylation in aging and diseases

Gudelj, I., Lauc, G., & Pezer, M. (2018) · Cellular Immunology · doi:10.1016/j.cellimm.2018.07.009 · Cited by 405 · see citing works

Fc glycans of therapeutic antibodies as critical quality attributes

Reusch, D., & Tejada, M. L. (2015) · Glycobiology · doi:10.1093/glycob/cwv065 · Cited by 406 · see citing works

The Challenge and Promise of Glycomics

Cummings, R. D., & Pierce, J. M. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.12.010 · Cited by 400 · see citing works

IgG antibodies to dengue enhanced for FcγRIIIA binding determine disease severity

Wang, T. T., Sewatanon, J., Memoli, M. J., Wrammert, J., Bournazos, S., Bhaumik, S. K., Pinsky, B. A., Chokephaibulkit, K., Onlamoon, N., Pattanapanyasat, K., et al. (2017) · Science · doi:10.1126/science.aai8128 · Cited by 371 · see citing works

Modulating IgG effector function by Fc glycan engineering

Li, T., DiLillo, D. J., Bournazos, S., Giddens, J. P., Ravetch, J. V., & Wang, L. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1702173114 · Cited by 316 · see citing works

The Immunoregulatory Roles of Antibody Glycosylation

Jennewein, M. F., & Alter, G. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.02.004 · Cited by 324 · see citing works

Regulation of autoantibody activity by the IL-23–TH17 axis determines the onset of autoimmune disease

Pfeifle, R., Rothe, T., Ipseiz, N., Scherer, H. U., Culemann, S., Steffen, U., Ackermann, J. A., Seefried, M., Kleyer, A., Uderhardt, S., et al. (2016) · Nature Immunology · doi:10.1038/ni.3579 · Cited by 320 · see citing works

Electrochemistry of Nonconjugated Proteins and Glycoproteins. Toward Sensors for Biomedicine and Glycomics

Paleček, E., Tkáč, J., Bartošík, M., Bertók, T., Ostatná, V., & Palecek, J. J. (2015) · Chemical Reviews · doi:10.1021/cr500279h · Cited by 319 · see citing works

A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs

Anthony, R. M., & Ravetch, J. V. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9405-6 · Cited by 317 · see citing works

Chemoenzymatic Glycoengineering of Intact IgG Antibodies for Gain of Functions

Huang, W., Giddens, J. P., Fan, S., Toonstra, C., & Wang, L. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3051266 · Cited by 307 · see citing works

Intravenous immunoglobulin in neurology—mode of action and clinical efficacy

Lünemann, J. D., Nimmerjahn, F., & Dalakas, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.253 · Cited by 304 · see citing works

Advances in the assessment and control of the effector functions of therapeutic antibodies

Jiang, X., Song, A., Bergelson, S., Arroll, T. W., Parekh, B. S., May, K. M. L., Chung, S., Strouse, R., Mire‐Sluis, A. R., & Schenerman, M. A. (2011) · Nature Reviews Drug Discovery · doi:10.1038/nrd3365 · Cited by 300 · see citing works

Antibody‐mediated modulation of immune responses

Nimmerjahn, F., & Ravetch, J. V. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00910.x · Cited by 284 · see citing works

Enzymes in the Synthesis of Glycoconjugates

Schmaltz, R. M., Hanson, S. R., & Wong, C. (2011) · Chemical Reviews · doi:10.1021/cr200113w · Cited by 284 · see citing works

IgG glycosylation analysis

Huhn, C., Selman, M. H. J., Ruhaak, L. R., Deelder, A. M., & Wuhrer, M. (2009) · PROTEOMICS · doi:10.1002/pmic.200800715 · Cited by 301 · see citing works

Management of Myocarditis-Related Cardiomyopathy in Adults

Tschöpe, C., Cooper, L. T., Torre‐Amione, G., & Linthout, S. V. (2019) · Circulation Research · doi:10.1161/circresaha.118.313578 · Cited by 280 · see citing works

Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity

Quast, I., Keller, C. W., Maurer, M., Giddens, J. P., Tackenberg, B., Wang, L., Münz, C., Nimmerjahn, F., Dalakas, M. C., & Lünemann, J. D. (2015) · Journal of Clinical Investigation · doi:10.1172/jci82695 · Cited by 270 · see citing works

Association of Systemic Lupus Erythematosus With Decreased Immunosuppressive Potential of the IgG Glycome

Vučković, F., Krištić, J., Gudelj, I., Teruel, M., Keser, T., Pezer, M., Pučić‐Baković, M., Štambuk, J., Trbojević‐Akmačić, I., Barrios, C., et al. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39273 · Cited by 270 · see citing works

IVIG-mediated effector functions in autoimmune and inflammatory diseases

Galeotti, C., Kaveri, S. V., & Bayry, J. (2017) · International Immunology · doi:10.1093/intimm/dxx039 · Cited by 272 · see citing works

IgA subclasses have different effector functions associated with distinct glycosylation profiles

Steffen, U., Koeleman, C. A. M., Sokolova, M. V., Bang, H., Kleyer, A., Rech, J., Unterweger, H., Schicht, M., Garreis, F., Hahn, J., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13992-8 · Cited by 257 · see citing works

Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss

Steffen, U., Lang, S. C., Pfeifle, R., Rombouts, Y., Frühbeißer, S., Amara, K., Bang, H., Lux, A., Koeleman, C. A. M., Baum, W., et al. (2015) · Nature Communications · doi:10.1038/ncomms7651 · Cited by 262 · see citing works

The IgG molecule as a biological immune response modifier: Mechanisms of action of intravenous immune serum globulin in autoimmune and inflammatory disorders

Ballow, M. C. (2010) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.10.030 · Cited by 254 · see citing works

Mass Spectrometry and the Emerging Field of Glycomics

Zaia, J. (2008) · Chemistry & Biology · doi:10.1016/j.chembiol.2008.07.016 · Cited by 249 · see citing works

Mass Spectrometry and Glycomics

Zaia, J. (2010) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2009.0146 · Cited by 243 · see citing works

Impaired inhibitory Fcγ receptor IIB expression on B cells in chronic inflammatory demyelinating polyneuropathy

Tackenberg, B., Jelčić, I., Baerenwaldt, A., Oertel, W. H., Sommer, N., Nimmerjahn, F., & Lünemann, J. D. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807319106 · Cited by 240 · see citing works

Site-specific chemical modification of recombinant proteins produced in mammalian cells by using the genetically encoded aldehyde tag

Wu, P., Shui, W., Carlson, B. L., Hu, N., Rabuka, D., Lee, J., & Bertozzi, C. R. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0807820106 · Cited by 237 · see citing works

Glycotherapy: New Advances Inspire a Reemergence of Glycans in Medicine

Hudak, J. E., & Bertozzi, C. R. (2013) · Chemistry & Biology · doi:10.1016/j.chembiol.2013.09.010 · Cited by 228 · see citing works

N-glycomic biomarkers of biological aging and longevity: A link with inflammaging

Dall’Olio, F., Vanhooren, V., Chen, C. C., Slagboom, P. E., Wuhrer, M., & Franceschi, C. (2012) · Ageing Research Reviews · doi:10.1016/j.arr.2012.02.002 · Cited by 231 · see citing works

In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway

Castilho, A., Strasser, R., Stadlmann, J., Grass, J., Jeż, J., Gattinger, P., Kunert, R., Quendler, H., Pabst, M., Leonard, R., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.088401 · Cited by 230 · see citing works

Intravenous immunoglobulins – understanding properties and mechanisms

Durandy, A., Kaveri, S. V., Kuijpers, T. W., Bašta, M., Miescher, S., Ravetch, J. V., & Rieben, R. (2009) · Clinical & Experimental Immunology · doi:10.1111/j.1365-2249.2009.04022.x · Cited by 229 · see citing works

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225 · see citing works

Glycan profiling of anti–citrullinated protein antibodies isolated from human serum and synovial fluid

Scherer, H. U., van der Woude, D., Ioan‐Facsinay, A., Bannoudi, H. E., Trouw, L. A., Wang, J., Häupl, T., Burmester, G. R., Deelder, A. M., Huizinga, T. W. J., et al. (2010) · Arthritis & Rheumatism · doi:10.1002/art.27414 · Cited by 223 · see citing works

Mass spectrometry in the analysis of N-linked and O-linked glycans

North, S. J., Hitchen, P. G., Haslam, S. M., & Dell, A. (2009) · Current Opinion in Structural Biology · doi:10.1016/j.sbi.2009.05.005 · Cited by 221 · see citing works

Quality Attributes of Recombinant Therapeutic Proteins: An Assessment of Impact on Safety and Efficacy as Part of a Quality by Design Development Approach

Eon‐Duval, A., Broly, H., & Gleixner, R. (2012) · Biotechnology Progress · doi:10.1002/btpr.1548 · Cited by 218 · see citing works

General mechanism for modulating immunoglobulin effector function

Sondermann, P., Pincetic, A., Maamary, J., Lammens, K., & Ravetch, J. V. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1307864110 · Cited by 218 · see citing works

Chemical assembly of N-glycoproteins: a refined toolbox to address a ubiquitous posttranslational modification

Unverzagt, C., & Kajihara, Y. (2013) · Chemical Society Reviews · doi:10.1039/c3cs35485g · Cited by 218 · see citing works

Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy

Mimura, Y., Katoh, T., Saldova, R., O’Flaherty, R., Izumi, T., Mimura‐Kimura, Y., Utsunomiya, T., Mizukami, Y., Yamamoto, K., Matsumoto, T., et al. (2017) · Protein & Cell · doi:10.1007/s13238-017-0433-3 · Cited by 217 · see citing works

Challenges of glycosylation analysis and control: an integrated approach to producing optimal and consistent therapeutic drugs

Zhang, P., Woen, S., Wang, T., Liau, B., Zhao, S., Chen, C., Yang, Y., Song, Z., Wormald, M. R., Yu, C., et al. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.01.006 · Cited by 212 · see citing works

Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease

Pagan, J. D., Kitaoka, M., & Anthony, R. M. (2017) · Cell · doi:10.1016/j.cell.2017.11.041 · Cited by 203 · see citing works

Anti-HA Glycoforms Drive B Cell Affinity Selection and Determine Influenza Vaccine Efficacy

Wang, T. T., Maamary, J., Tan, G. S., Bournazos, S., Davis, C. W., Krammer, F., Schlesinger, S. J., Palese, P., Ahmed, R., & Ravetch, J. V. (2015) · Cell · doi:10.1016/j.cell.2015.06.026 · Cited by 201 · see citing works

A common glycan structure on immunoglobulin G for enhancement of effector functions

Lin, C., Tsai, M.-H., Li, S., Tsai, T.-I., Chu, K., Liu, Y.-C., Lai, M.-Y., Wu, C.-Y., Tseng, Y.-C., Shivatare, S. S., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1513456112 · Cited by 200 · see citing works

Modulation of the cellular immune system by intravenous immunoglobulin

Tha‐In, T., Bayry, J., Metselaar, H. J., Kaveri, S. V., & Kwekkeboom, J. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.08.004 · Cited by 199 · see citing works

The history of IgG glycosylation and where we are now

Cobb, B. A. (2019) · Glycobiology · doi:10.1093/glycob/cwz065 · Cited by 195 · see citing works

Functional diversification of IgGs through Fc glycosylation

Wang, T. T., & Ravetch, J. V. (2019) · Journal of Clinical Investigation · doi:10.1172/jci130029 · Cited by 193 · see citing works

Novel roles for the IgG Fc glycan

Anthony, R. M., Wermeling, F., & Ravetch, J. V. (2012) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06305.x · Cited by 186 · see citing works

NMR analysis demonstrates immunoglobulin G N-glycans are accessible and dynamic

Barb, A. W., & Prestegard, J. H. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.511 · Cited by 186 · see citing works

A combined method for producing homogeneous glycoproteins with eukaryotic N-glycosylation

Schwarz, F., Huang, W., Li, C., Schulz, B. L., Lizak, C., Palumbo, A., Numao, S., Neri, D., Aebi, M., & Wang, L. (2010) · Nature Chemical Biology · doi:10.1038/nchembio.314 · Cited by 186 · see citing works

Antibody glycosylation in inflammation, disease and vaccination

Alter, G., Ottenhoff, T. H. M., & Joosten, S. A. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.05.003 · Cited by 186 · see citing works

Influence of N-glycosylation on effector functions and thermal stability of glycoengineered IgG1 monoclonal antibody with homogeneous glycoforms

Wada, R., Matsui, M., & Kawasaki, N. (2019) · mAbs · doi:10.1080/19420862.2018.1551044 · Cited by 186 · see citing works

Immunotherapy in myasthenia gravis in the era of biologics

Dalakas, M. C. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0110-z · Cited by 182 · see citing works

Biological function of sialic acid and sialylation in human health and disease

Zhu, W., Zhou, Y., Guo, L., & Feng, S. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-02180-3 · Cited by 183 · see citing works

Differential antibody glycosylation in autoimmunity: sweet biomarker or modulator of disease activity?

Seeling, M., Brückner, C., & Nimmerjahn, F. (2017) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2017.146 · Cited by 179 · see citing works

Aglycosylated immunoglobulin G 1 variants productively engage activating Fc receptors

Sazinsky, S. L., Ott, R. G., Silver, N. W., Tidor, B., Ravetch, J. V., & Wittrup, K. D. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809257105 · Cited by 175 · see citing works

The immunoglobulin G1 N-glycan composition affects binding to each low affinity Fc γ receptor

Subedi, G. P., & Barb, A. W. (2016) · mAbs · doi:10.1080/19420862.2016.1218586 · Cited by 175 · see citing works

Marginal zone macrophages suppress innate and adaptive immunity to apoptotic cells in the spleen

McGaha, T. L., Chen, Y., Ravishankar, B., van Rooijen, N., & Karlsson, M. C. I. (2011) · Blood · doi:10.1182/blood-2010-11-320028 · Cited by 173 · see citing works

Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis

Ohmi, Y., Ise, W., Harazono, A., Takakura, D., Fukuyama, H., Baba, Y., Narazaki, M., Shoda, H., Takahashi, N., Ohkawa, Y., et al. (2016) · Nature Communications · doi:10.1038/ncomms11205 · Cited by 171 · see citing works

Optimization of Fc-mediated effector functions of monoclonal antibodies

Strohl, W. R. (2009) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2009.10.011 · Cited by 169 · see citing works

Advances in Enzymatic Glycoside Synthesis

Danby, P. M., & Withers, S. G. (2016) · ACS Chemical Biology · doi:10.1021/acschembio.6b00340 · Cited by 167 · see citing works

Sialylation of immunoglobulin E is a determinant of allergic pathogenicity

Shade, K.-T., Conroy, M. E., Washburn, N., Kitaoka, M., Huynh, D. J., Laprise, E., Patil, S. U., Shreffler, W. G., & Anthony, R. M. (2020) · Nature · doi:10.1038/s41586-020-2311-z · Cited by 167 · see citing works

Chemoenzymatic Synthesis and Fcγ Receptor Binding of Homogeneous Glycoforms of Antibody Fc Domain. Presence of a Bisecting Sugar Moiety Enhances the Affinity of Fc to FcγIIIa Receptor

Zou, G., Ochiai, H., Huang, W., Yang, Q., Li, C., & Wang, L. (2011) · Journal of the American Chemical Society · doi:10.1021/ja208390n · Cited by 167 · see citing works

To B or not to B: B cells and the Th2-type immune response to helminths

Harris, N., & Gause, W. C. (2011) · Trends in Immunology · doi:10.1016/j.it.2010.11.005 · Cited by 166 · see citing works

Subclass-specific IgG glycosylation is associated with markers of inflammation and metabolic health

Plomp, R., Ruhaak, L. R., Uh, H., Reiding, K. R., Selman, M. H. J., Houwing‐Duistermaat, J. J., Slagboom, P. E., Beekman, M., & Wuhrer, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-12495-0 · Cited by 164 · see citing works

Chemical and Chemoenzymatic Synthesis of Glycoproteins for Deciphering Functions

Wang, L., & Amin, M. A. (2014) · Chemistry & Biology · doi:10.1016/j.chembiol.2014.01.001 · Cited by 163 · see citing works

Fc-Glycosylation of IgG1 is Modulated by B-cell Stimuli

Wang, J., Balog, C. I. A., Stavenhagen, K., Koeleman, C. A. M., Scherer, H. U., Selman, M. H. J., Deelder, A. M., Huizinga, T. W. J., Toes, R. E. M., & Wuhrer, M. (2011) · Molecular & Cellular Proteomics · doi:10.1074/mcp.m110.004655 · Cited by 162 · see citing works

A single glycan on IgE is indispensable for initiation of anaphylaxis

Shade, K.-T., Platzer, B., Washburn, N., Mani, V., Bartsch, Y. C., Conroy, M. E., Pagan, J. D., Bosques, C. J., Mempel, T. R., Fiebiger, E., et al. (2015) · The Journal of Experimental Medicine · doi:10.1084/jem.20142182 · Cited by 154 · see citing works

Inhibition of B cell receptor-mediated activation of primary human B cells by coengagement of CD19 and FcγRIIb with Fc-engineered antibodies

Chu, S. Y., Voštiar, I., Karki, S., Moore, G. L., Lazar, G. A., Pong, E., Joyce, P. F., Szymkowski, D. E., & Desjarlais, J. R. (2008) · Molecular Immunology · doi:10.1016/j.molimm.2008.06.027 · Cited by 156 · see citing works

Changes in IgG and total plasma protein glycomes in acute systemic inflammation

Novokmet, M., Lukić, E., Vučković, F., Đurić, Ž., Keser, T., Rajšl, K., Remondini, D., Castellani, G., Gašparović, H., Gornik, O., et al. (2014) · Scientific Reports · doi:10.1038/srep04347 · Cited by 156 · see citing works

Dendritic cell immunoreceptor: A novel receptor for intravenous immunoglobulin mediates induction of regulatory T cells

Massoud, A. H., Yona, M., Xue, D., Chouiali, F., Alturaihi, H., Ablona, A., Mourad, W. M., Piccirillo, C. A., & Mazer, B. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.029 · Cited by 155 · see citing works

Structural Characterization of Anti-Inflammatory Immunoglobulin G Fc Proteins

Ahmed, A. A., Giddens, J. P., Pincetic, A., Lomino, J. V., Ravetch, J. V., Wang, L., & Björkman, P. J. (2014) · Journal of Molecular Biology · doi:10.1016/j.jmb.2014.07.006 · Cited by 154 · see citing works

FcγRs in Health and Disease

Nimmerjahn, F., & Ravetch, J. V. (2010) · Current topics in microbiology and immunology · doi:10.1007/82_2010_86 · Cited by 154 · see citing works

Advances in the understanding of the mechanism of action of IVIg

Hartung, H. (2008) · Journal of Neurology · doi:10.1007/s00415-008-3002-0 · Cited by 152 · see citing works

The Role of Fc Receptors on the Effectiveness of Therapeutic Monoclonal Antibodies

Gogesch, P., Dudek, S., van Zandbergen, G., Waibler, Z., & Anzaghe, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168947 · Cited by 152 · see citing works

Comprehensive characterization of N- and O- glycosylation of SARS-CoV-2 human receptor angiotensin converting enzyme 2

Shajahan, A., Archer‐Hartmann, S. A., Supekar, N. T., Gleinich, A. S., Heiß, C., & Azadi, P. (2020) · Glycobiology · doi:10.1093/glycob/cwaa101 · Cited by 146 · see citing works

Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination

Mahan, A. E., Jennewein, M. F., Suscovich, T. J., Dionne, K., Tedesco, J., Chung, A. W., Streeck, H., Pau, M. G., Schuitemaker, H., Francis, D., et al. (2016) · PLoS Pathogens · doi:10.1371/journal.ppat.1005456 · Cited by 149 · see citing works

N-Glycosylation Design and Control of Therapeutic Monoclonal Antibodies

Sha, S., Agarabi, C. D., Brorson, K., Lee, D., & Yoon, S. (2016) · Trends in biotechnology · doi:10.1016/j.tibtech.2016.02.013 · Cited by 149 · see citing works

Fcγ receptor pathways during active and passive immunization

Bournazos, S., & Ravetch, J. V. (2015) · Immunological Reviews · doi:10.1111/imr.12343 · Cited by 147 · see citing works

Intravenous immunoglobulin therapy in rheumatic diseases

Bayry, J., Negi, V. S., & Kaveri, S. V. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.61 · Cited by 145 · see citing works

Emerging methods for the production of homogeneous human glycoproteins

Rich, J. R., & Withers, S. G. (2008) · Nature Chemical Biology · doi:10.1038/nchembio.148 · Cited by 145 · see citing works

Fc-Glycosylation Influences Fcγ Receptor Binding and Cell-Mediated Anti-HIV Activity of Monoclonal Antibody 2G12

Forthal, D. N., Gach, J. S., Landucci, G., Jeż, J., Strasser, R., Kunert, R., & Steinkellner, H. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.1002600 · Cited by 145 · see citing works

Applications of ion mobility mass spectrometry for high throughput, high resolution glycan analysis

Gray, C., Thomas, B., Upton, R., Migas, L. G., Eyers, C. E., Barran, P. E., & Flitsch, S. L. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.02.003 · Cited by 143 · see citing works

The role of sialic acid as a modulator of the anti-inflammatory activity of IgG

Böhm, S., Schwab, I., Lux, A., & Nimmerjahn, F. (2012) · Seminars in Immunopathology · doi:10.1007/s00281-012-0308-x · Cited by 143 · see citing works

Emerging Technologies for Making Glycan-Defined Glycoproteins

Wang, L., & Lomino, J. V. (2011) · ACS Chemical Biology · doi:10.1021/cb200429n · Cited by 137 · see citing works

Towards the implementation of quality by design to the production of therapeutic monoclonal antibodies with desired glycosylation patterns

del Val, I. J., Kontoravdi, C., & Nagy, J. M. (2010) · Biotechnology Progress · doi:10.1002/btpr.470 · Cited by 139 · see citing works

Fcγ Receptor Heterogeneity in Leukocyte Functional Responses

Rosales, C. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00280 · Cited by 139 · see citing works

The role and function of Fcγ receptors on myeloid cells

Bournazos, S., Wang, T. T., & Ravetch, J. V. (2016) · Microbiology Spectrum · doi:10.1128/microbiolspec.mchd-0045-2016 · Cited by 138 · see citing works

with a Recombinant IgG Fc Recapitulation of IVIG Anti-Inflammatory Activity

Anthony, R. M. (2008)

Research Highlights

Okoreeh, M. K., & Luo, X. (2026) · Transplantation · doi:10.1097/tp.0000000000005610

The anti-inflammatory activity of IgG is enhanced by co-engagement of type I and II Fc receptors

Jones, A., Marino, A. E., Martynyuk, T., Bournazos, S., & Ravetch, J. V. (2025) · Science · doi:10.1126/science.adv2927 · Cited by 11 · see citing works

Controlled tetra-Fc sialylation of IVIg results in a drug candidate with consistent enhanced anti-inflammatory activity

Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225 · see citing works

Novel Fc receptors mediating the anti-inflammatory properties of IgG

Ravetch, J. V. (2010)